Bulent Ozpolat Selected Research

Adenocarcinoma

1/2022	miRNA-193b-5p Suppresses Pancreatic Cancer Cell Proliferation, Invasion, Epithelial Mesenchymal Transition, and Tumor Growth by Inhibiting eEF2K.
3/2018	Lycopene Protects Against Spontaneous Ovarian Cancer Formation in Laying Hens.
1/2017	Pancreatic Cancer Stem Cells and Therapeutic Approaches.
11/2014	Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bulent Ozpolat Research Topics

Disease

86	Neoplasms (Cancer) 05/2024 - 05/2003
19	Breast Neoplasms (Breast Cancer) 07/2023 - 07/2008
18	Triple Negative Breast Neoplasms 10/2023 - 07/2015
16	Neoplasm Metastasis (Metastasis) 02/2024 - 05/2010
16	Carcinogenesis 02/2024 - 05/2010
15	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 04/2014
11	Pancreatic Neoplasms (Pancreatic Cancer) 03/2020 - 03/2007
8	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 12/2012
7	Acute Promyelocytic Leukemia 01/2019 - 05/2002
4	Leiomyoma (Uterine Fibroids) 05/2024 - 11/2016
4	Adenocarcinoma 01/2022 - 11/2014
4	Hypoxia (Hypoxemia) 01/2020 - 04/2010
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2023 - 05/2004
3	Lung Neoplasms (Lung Cancer) 01/2023 - 10/2018
3	Leukemia 07/2013 - 05/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2017
2	Disease Progression 01/2022 - 03/2016
2	Starvation 01/2019 - 03/2018
2	Glioma (Gliomas) 06/2015 - 03/2014
2	Liver Neoplasms (Liver Cancer) 01/2014 - 01/2014
1	Human Influenza (Influenza) 07/2022

Drug/Important Bio-Agent (IBA)

22	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2007
21	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2007
19	MicroRNAs (MicroRNA)IBA 02/2024 - 01/2016
15	Phosphotransferases (Kinase)IBA 01/2024 - 01/2014
13	Elongation Factor 2 KinaseIBA 10/2023 - 01/2012
8	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019 - 05/2002
7	IntegrinsIBA 05/2021 - 01/2014
7	Messenger RNA (mRNA)IBA 01/2020 - 03/2007
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2014
6	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2014 - 01/2007
5	Beclin-1IBA 01/2021 - 09/2007
4	Serotonin (5 Hydroxytryptamine)IBA 11/2022 - 01/2014
4	Lipid NanoparticlesIBA 07/2022 - 01/2021
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 06/2015
4	AndrogensIBA 01/2019 - 12/2012
4	Cyclin D1IBA 10/2018 - 05/2010
4	Matrix Metalloproteinases (MMPs)IBA 05/2015 - 01/2014
3	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 02/2019
3	Untranslated RNA (Noncoding RNA)IBA 02/2024 - 01/2021
3	Estrogens (Estrogen)FDA Link 10/2022 - 06/2013
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 04/2014
3	Docetaxel (Taxotere)FDA Link 01/2021 - 11/2011
3	Serotonin ReceptorsIBA 11/2016 - 01/2014
3	Arsenic Trioxide (Trisenox)FDA Link 01/2012 - 07/2008
2	Simvastatin (Zocor)FDA LinkGeneric 05/2024 - 08/2022
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2023 - 07/2015
2	NucleoproteinsIBA 07/2022 - 09/2004
2	Peptides (Polypeptides)IBA 07/2022 - 04/2014
2	Protein Kinases (Protein Kinase)IBA 01/2022 - 03/2007
2	Chalcone (Benzalacetophenone)IBA 06/2021 - 04/2021
2	LipidsIBA 04/2021 - 02/2014
2	Activating Transcription Factor 4IBA 01/2021 - 01/2019
2	NF-kappa B (NF-kB)IBA 01/2021 - 10/2018
2	thymoquinoneIBA 01/2021 - 10/2018
2	Sucrose (Saccharose)IBA 03/2020 - 04/2019
2	Hyaluronic Acid (Hyaluronan)IBA 03/2020 - 04/2019
2	NanogelsIBA 03/2020 - 04/2019
2	GoldIBA 08/2017 - 01/2016
2	Estrogen ReceptorsIBA 02/2017 - 09/2013
2	Antineoplastic Agents (Antineoplastics)IBA 07/2015 - 04/2010
2	CytokinesIBA 05/2015 - 02/2012
2	rottlerinIBA 01/2014 - 03/2007
2	Tamoxifen FDA LinkGeneric 06/2013 - 04/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2013 - 01/2012
2	Retinoic Acid 4-Hydroxylase (CYP26B1)IBA 10/2005 - 05/2002
2	RetinoidsIBA 05/2004 - 05/2003
1	ferric oxide (iron oxide)IBA 02/2024
1	alvocidib (flavopiridol)IBA 09/2023
1	flavoneIBA 09/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2023
1	serotonin 7 receptorIBA 11/2022
1	Liposomes (Liposome)IBA 08/2022
1	Etodolac (Lodine)FDA LinkGeneric 07/2022
1	AntigensIBA 07/2022
1	Hemagglutinins (Hemagglutinin)IBA 07/2022
1	Epidermal Growth Factor (EGF)IBA 07/2022
1	AntagomirsIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	coumarinIBA 11/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2021
1	CarcinogensIBA 02/2021
1	Eukaryotic Initiation Factor-4EIBA 02/2021
1	Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA 02/2021
1	Abiraterone AcetateIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Mercaptoethanol (2 Mercaptoethanol)IBA 01/2021
1	Androgen Antagonists (Antiandrogens)IBA 01/2021
1	ChemokinesIBA 01/2021
1	src-Family KinasesIBA 01/2021

Therapy/Procedure

43	Therapeutics 02/2024 - 07/2008
11	Drug Therapy (Chemotherapy) 11/2023 - 07/2008
4	Immunotherapy 01/2023 - 01/2017
3	Radiotherapy 01/2024 - 04/2010
3	Precision Medicine 01/2022 - 01/2016
2	Chemoprevention 01/2019 - 03/2018
2	Intravenous Administration 01/2018 - 02/2014
1	RNAi Therapeutics 01/2022
1	Aftercare (After-Treatment) 01/2021